Literature DB >> 16373609

Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology.

Samuel A Wickline1, Anne M Neubauer, Patrick Winter, Shelton Caruthers, Gregory Lanza.   

Abstract

The role of nanotechnology in cardiovascular diagnosis is expanding rapidly. The goal of this brief review is to illustrate selected examples of nanosystems that have been applied to the arenas of atherosclerosis, thrombosis, and vascular biology. The technologies for producing targeted nanosystems are multifarious and reflect end uses in many cases. The results to date indicate rapid growth of interest and capability in the field. The future of cardiovascular diagnosis already is being impacted by nanosystems that can both diagnose pathology and treat it with targeted delivery systems.

Entities:  

Mesh:

Year:  2005        PMID: 16373609     DOI: 10.1161/01.ATV.0000201069.47550.8b

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

2.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Authors:  Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

Review 3.  Noninvasive imaging of apoptosis in cardiovascular disease.

Authors:  Ethan Chauncey Korngold; Farouc Amin Jaffer; Ralph Weissleder; David Edwin Sosnovik
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

4.  Nanomedicine: Addressing Cardiovascular Disease and Cardiovascular Tissue Regeneration.

Authors:  Rebekah A Neal; Olugbemisola Oredein-McCoy; Edward A Botchwey
Journal:  Curr Bioact Compd       Date:  2009

5.  Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function.

Authors:  Kristin P Bibee; Ya-Jian Cheng; James K Ching; Jon N Marsh; Allison J Li; Richard M Keeling; Anne M Connolly; Paul T Golumbek; Jacob W Myerson; Grace Hu; Junjie Chen; William D Shannon; Gregory M Lanza; Conrad C Weihl; Samuel A Wickline
Journal:  FASEB J       Date:  2014-02-05       Impact factor: 5.191

Review 6.  Echographic imaging of tumoral cells through novel nanosystems for image diagnosis.

Authors:  Marco Di Paola; Fernanda Chiriacò; Giulia Soloperto; Francesco Conversano; Sergio Casciaro
Journal:  World J Radiol       Date:  2014-07-28

Review 7.  Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.

Authors:  Khalid Khalaf Alharbi; Yazeed A Al-Sheikh
Journal:  Saudi J Biol Sci       Date:  2013-11-19       Impact factor: 4.219

Review 8.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

9.  Angiogenesis is required for stress fracture healing in rats.

Authors:  Ryan E Tomlinson; Jennifer A McKenzie; Anne H Schmieder; Gregory R Wohl; Gregory M Lanza; Matthew J Silva
Journal:  Bone       Date:  2012-10-05       Impact factor: 4.398

10.  TSPO targeted dendrimer imaging agent: synthesis, characterization, and cellular internalization.

Authors:  Lynn E Samuelson; Madeline J Dukes; Colette R Hunt; Jonathan D Casey; Darryl J Bornhop
Journal:  Bioconjug Chem       Date:  2009-11       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.